Senestech (SNES) Projected to Post Earnings on Thursday

Senestech (NASDAQ:SNES) will likely be posting its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect Senestech to post earnings of ($0.33) per share and revenue of $0.6320 million for the quarter. Individuals may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Thursday, May 14, 2026 at 5:00 PM ET.

Senestech (NASDAQ:SNES) last issued its earnings results on Thursday, March 12th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.30) by $0.01. The company had revenue of $0.42 million during the quarter, compared to analysts’ expectations of $0.78 million. Senestech had a negative return on equity of 78.74% and a negative net margin of 287.39%. On average, analysts expect Senestech to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Senestech Trading Down 1.7%

SNES stock traded down $0.03 during trading on Wednesday, hitting $1.48. 6,049 shares of the company traded hands, compared to its average volume of 44,978. The firm has a market capitalization of $7.77 million, a PE ratio of -0.53 and a beta of 0.18. Senestech has a 1 year low of $1.41 and a 1 year high of $6.24. The company has a 50-day moving average of $1.79 and a 200-day moving average of $2.29. The company has a debt-to-equity ratio of 0.02, a quick ratio of 11.36 and a current ratio of 12.61.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a report on Friday, March 27th. One research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold”.

Insiders Place Their Bets

In related news, major shareholder Glenbrook Capital Management bought 19,725 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was bought at an average cost of $1.79 per share, for a total transaction of $35,307.75. Following the acquisition, the insider directly owned 890,635 shares of the company’s stock, valued at $1,594,236.65. The trade was a 2.26% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In the last three months, insiders bought 294,165 shares of company stock worth $596,552. Corporate insiders own 5.29% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC raised its position in Senestech by 35.2% during the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock valued at $306,000 after purchasing an additional 37,165 shares during the last quarter. DRW Securities LLC raised its position in Senestech by 171.1% during the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock valued at $176,000 after purchasing an additional 51,818 shares during the last quarter. Jane Street Group LLC bought a new position in Senestech during the 2nd quarter valued at approximately $161,000. Millennium Management LLC bought a new position in Senestech during the 3rd quarter valued at approximately $126,000. Finally, XTX Topco Ltd bought a new position in Senestech during the 4th quarter valued at approximately $54,000. Institutional investors own 5.19% of the company’s stock.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.